Alyeska Investment Group’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$210M Buy
1,062,278
+198,880
+23% +$38.3M 0.59% 32
2025
Q4
$159M Buy
863,398
+592,315
+218% +$104M 0.45% 48
2025
Q3
$41.6M Buy
271,083
+14,427
+6% +$2.18M 0.13% 195
2025
Q2
$35.9M Sell
256,656
-195,844
-43% -$27.4M 0.13% 201
2025
Q1
$66.5M Sell
452,500
-1,061,256
-70% -$154M 0.27% 106
2024
Q4
$198M Buy
1,513,756
+1,041,823
+221% +$146M 0.75% 20
2024
Q3
$73.5M Sell
471,933
-737,515
-61% -$119M 0.38% 91
2024
Q2
$189M Sell
1,209,448
-188,393
-13% -$28.3M 1.09% 16
2024
Q1
$189M Buy
1,397,841
+1,110,342
+386% +$147M 1.18% 8
2023
Q4
$38.7M Sell
287,499
-413,429
-59% -$53.7M 0.26% 124
2023
Q3
$94.9M Buy
+700,928
New +$95.7M 0.65% 38
2020
Q3
Sell
-11,419
Closed -$1.21M 468
2020
Q2
$1.21M Buy
+11,419
New +$1.18M 0.02% 390
2018
Q4
Sell
-13,143
Closed -$1.04M 368
2018
Q3
$1.04M Buy
+13,143
New +$994K 0.01% 346
2018
Q1
Sell
-1,178,615
Closed -$81.8M 446
2017
Q4
$81.8M Buy
+1,178,615
New +$79.5M 0.67% 51

Other funds holding AZN